Pre-Closed Period Update

Dechra Pharmaceuticals PLC
05 July 2005






Issued by Citigate Dewe Rogerson Ltd, Birmingham
Date: Tuesday, 5 July 2005
                                                               Embargoed: 7.00am

Dechra Pharmaceuticals PLC issues the following pre-closed period update ahead
of publication of the Group's preliminary results for the year ended 30 June
2005 which are scheduled to be announced on Tuesday, 6 September 2005.

Pre-Closed Period Update

Both our Services and Pharmaceuticals Divisions have continued to perform well
building on the good growth achieved in the first half, reflecting the on-going
improvement in market conditions, and further penetration of new products and
services within the veterinary markets.

The development programme for our own branded licensed veterinary product
portfolio into North America, Europe and Japan is progressing; we expect to give
further details in our preliminary announcement in September.

The Board expects the results for the full year ended 30 June 2005 to be in line
with management expectations.

All areas of our business are performing well and the Group expects to make
further progress in this new financial year.




Enquiries:
Ian Page, Chief Executive
Simon Evans, Group Finance Director
Dechra Pharmaceuticals PLC                       Fiona Tooley
Tel: [phone]                                Citigate Dewe Rogerson
07775 642222 (IP)                                Tel: [phone]
07775 642220 (SE)                                Mobile: [phone]
www.dechra.com





                      This information is provided by RNS
            The company news service from the London Stock Exchange